- Home
- MBX vs EAF Comparison
MBX vs EAF Comparison
Compare MBX & EAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBX
- EAF
- Stock Information
- Founded
- MBX 2018
- EAF 1886
- Country
- MBX United States
- EAF United States
- Employees
- MBX N/A
- EAF N/A
- Industry
- MBX
- EAF Industrial Machinery/Components
- Sector
- MBX
- EAF Energy
- Exchange
- MBX NYSE
- EAF Nasdaq
- Market Cap
- MBX 381.4M
- EAF 335.5M
- IPO Year
- MBX 2024
- EAF 1995
- Fundamental
- Price
- MBX $13.29
- EAF $1.00
- Analyst Decision
- MBX Strong Buy
- EAF Hold
- Analyst Count
- MBX 5
- EAF 7
- Target Price
- MBX $37.40
- EAF $1.50
- AVG Volume (30 Days)
- MBX 365.8K
- EAF 4.4M
- Earning Date
- MBX 08-16-2025
- EAF 07-25-2025
- Dividend Yield
- MBX N/A
- EAF N/A
- EPS Growth
- MBX N/A
- EAF N/A
- EPS
- MBX N/A
- EAF N/A
- Revenue
- MBX N/A
- EAF $514,037,000.00
- Revenue This Year
- MBX N/A
- EAF N/A
- Revenue Next Year
- MBX N/A
- EAF $26.22
- P/E Ratio
- MBX N/A
- EAF N/A
- Revenue Growth
- MBX N/A
- EAF N/A
- 52 Week Low
- MBX $4.81
- EAF $0.52
- 52 Week High
- MBX $27.50
- EAF $2.53
- Technical
- Relative Strength Index (RSI)
- MBX N/A
- EAF 43.42
- Support Level
- MBX N/A
- EAF $0.90
- Resistance Level
- MBX N/A
- EAF $0.98
- Average True Range (ATR)
- MBX 0.00
- EAF 0.09
- MACD
- MBX 0.00
- EAF -0.03
- Stochastic Oscillator
- MBX 0.00
- EAF 11.34
About MBX MBX BIOSCIENCES INC
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.
About EAF GrafTech International Ltd.
GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. The company has only reportable segment, Industrial Materials, is comprised of its two product categories: graphite electrodes and petroleum needle coke products. Petroleum needle coke is key raw material used in the production of graphite electrodes.